Australia's Monash IVF Group rises after CEO departure
12/06/2025 01:41
** Monash IVF Group's MVF.AX shares rise as much as 5.8% to A$0.64 ** Monash announces the departure of CEO and MD Michael Knaap and the appointment of Malik Jainudeen as his successor ** Shares fell nearly 27% to A$0.545 earlier this week after the IVF provider said there had been a second fertility mix-up at its Melbourne lab ** YTD losses stand at 50.4% (Reporting by Sneha Kumar in Bengaluru) ((Sneha.kumar@thomsonreuters.com;))
Recent news on Monash IVF
See all newsBrief: Monash IVF Group Appoints Matt Harrington As Chief Financial Officer
Australia's Monash IVF at over four-month high on upbeat FY27 outlook
Brief: Monash IVF Group Posts FY Revenue AUD 269.5 Million
Brief: Monash IVF Group Appoints Catherine West As Chair-Elect
Brief: Memphasys Executes Supply Agreement With Monash IVF Group